COVID-SEROINDEX

Welcome to the Brand page for “COVID-SEROINDEX”, which is offered here for Diagnostic agents, preparations and substances other than for medical or veterinary purposes; diagnostic preparations and reagents for scientific or medical research use; diagnostic preparations and reagents for clinical or medical laboratory use; diagnostic agents, preparations, substances and diagnostic test kits used for detecting and analyzing antibodies, enzymes, antigens, diseases, viruses and infections for scientific, laboratory or medical research use; test kits consisting of diagnostic preparations, reagents, assays, solutions and buffers for clinical or medical laboratory testing and analysis of sars-cov-2, covid-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; test kits comprised of diagnostic preparations, reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection for scientific or medical research use; diagnostic preparations for scientific or research purposes related to vaccines in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; diagnostic assays, media, solutions and buffers for clinical use; diagnostic agents for carrying out serologic tests for clinical purposes; diagnostic reagents for serologic tests of infections for clinical purposes; diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for clinical and research purposes; diagnostic preparations for clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of sars-cov-2, covid-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to sars-cov-2 or covid-19;.

Its status is currently believed to be active. Its class is unavailable. “COVID-SEROINDEX” is believed to be currently owned by “Kantaro Biosciences LLC”.